Comprehensive Neural Implants Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Neural Implants Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for neural implants has expanded swiftly over the past few years. Projected growth shows an increase from $5.39 billion in 2024 to $5.96 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.6%. The expansion during the historical period can be attributed to factors such as the development of well-structured healthcare facilities, an increase in the aging population, a shift towards minimally invasive procedures, higher demand for customized treatment options, and the availability of better healthcare infrastructure.

Neural Implants Market Size Forecast: What's the Projected Valuation by 2029?
The market for neural implants is projected to experience accelerated growth rate in the coming years, reaching a total value of $8.8 billion in 2029 while maintaining a CAGR of 10.2%. This expected surge within the forecast period can be linked to several factors such as the increasing prevalence of neurological conditions, enhanced patient awareness about innovative treatment methods for these disorders, increased accessibility to effective gadgets, a growing inclination for MR-conditional brain implants, and an uptrend in the adoption of high-frequency neuromodulation therapy. Major developmental indicators to watch out for during the forecast period will be the emergence of new product innovations, advancements in technology, progress in the sector of neuroprosthetics, and the incorporation of deep learning algorithms with neural implants.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neural-implants-global-market-report

What Are the Drivers Transforming the Neural Implants Market?
An increase in neurological disorders is projected to drive the growth of the neural implants market. Neurological disorders pertain to any anomaly in the nervous system's structure, biochemistry, or electricity, including issues within the brain, spinal cord, or peripheral nerves. These disorders have observed a surge due to factors such as a growing aging population, genetic factors, and changes in diagnostic standards. Neural implants, which interact directly with the nervous system, offer treatment and management for various neurological diseases, enhancing or restoring neural functions. Tailored approaches provided by these implants can potentially improve the efficacy of treatment while minimizing undesirable outcomes, especially in diseases like Parkinson's, epilepsy, and spinal cord injuries. For example, in March 2022, the Alzheimer's Association, a US volunteer health organization focused on Alzheimer's disease care, reported that close to 7 million Americans aged 65 or above were living with Alzheimer's dementia. This number could balloon to 13.8 million by 2060. Health and long-term care costs for people living with dementia are estimated to hit $360 billion by 2024 and nearly $1 trillion by 2050. Consequently, the increasing incidence of neurological disorders is fueling the expansion of the neural implants market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15618&type=smp

What Long-Term Trends Will Define the Future of the Neural Implants Market?
Leading firms in the neural implant market are concentrating their efforts on the creation of novel products such as deep brain stimulation (DBS) devices. The objective is to both manage movement disorders like Parkinson's disease and essential tremors, and to establish competitive supremacy in the market. DBS devices are essentially medical implants capable of mitigating neurological disorders by transmitting electrical impulses to specific brain areas. To illustrate, in January 2024, Abbott Laboratories, a renowned US company specializing in medical devices and healthcare, introduced the Liberta RC. This is applauded as the smallest rechargeable DBS device worldwide that has remote programming capabilities for treating individuals suffering from movement disorders. It boasts the lowest recharge requirement among all FDA-acknowledged DBS systems, necessitating roughly 10 recharge sessions per annum for the majority of its users. This asset is integrated into Abbott's unique NeuroSphere virtual clinic, whereby customers can connect with clinicians, verify correct settings and functionality, and procure remotely updated treatment settings. It incorporates a wireless charging system that can be positioned over the product, thereby facilitating user mobility during the charging period. The device offers convenient notifications and specialized settings, thereby assuring a personalized charging experience for all users.

Which Segments in the Neural Implants Market Offer the Most Profit Potential?
The neural implants market covered in this report is segmented -

1) By Product: F And B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS)
2) By Application: Chronic Pain, Parkinson's Disease (PD), Epilepsy, Other Applications
3) By End-User: Hospitals, Specialized Neurological Centers (SNCs), Outpatient Surgery Centers

Subsegments:
1) By F And B Spinal Cord Stimulation (Scs): Traditional Spinal Cord Stimulation, High-Frequency Spinal Cord Stimulation, Burst Spinal Cord Stimulation
2) By Deep Brain Stimulation (Dbs): Subthalamic Nucleus (Stn) Dbs, Globus Pallidus Internus (Gpi) Dbs, Ventral Intermediate Nucleus (Vim) Dbs
3) By Vagus Nerve Stimulation (Vns): Implantable Vagus Nerve Stimulators, Non-Invasive Vagus Nerve Stimulators

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15618&type=smp

Which Firms Dominate the Neural Implants Market by Market Share and Revenue in 2025?
Major companies operating in the neural implants market are Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Smith & Nephew plc, Integra LifeSciences, Cochlear Ltd., LivaNova PLC, Renishaw plc, MicroPort Scientific Corporation, Nevro Corp., Inspire Medical Systems Inc., Cyberonics Inc., Axonics Modulation Technologies Inc., Saluda Medical, NeuroPace Inc., Fisher Wallace, BioControl Medical, Cerbomed GmbH, Nuvectra Corporation

Which Regions Offer the Highest Growth Potential in the Neural Implants Market?
North America was the largest region in the neural implants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neural implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15618

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.